SG11202009013QA - Method of Delivering Amphiphilic Bioactive Substances Targeting the Respiratory Tract - Google Patents
Method of Delivering Amphiphilic Bioactive Substances Targeting the Respiratory TractInfo
- Publication number
- SG11202009013QA SG11202009013QA SG11202009013QA SG11202009013QA SG11202009013QA SG 11202009013Q A SG11202009013Q A SG 11202009013QA SG 11202009013Q A SG11202009013Q A SG 11202009013QA SG 11202009013Q A SG11202009013Q A SG 11202009013QA SG 11202009013Q A SG11202009013Q A SG 11202009013QA
- Authority
- SG
- Singapore
- Prior art keywords
- delivering
- respiratory tract
- bioactive substances
- substances targeting
- amphiphilic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
- A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
- A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862647843P | 2018-03-26 | 2018-03-26 | |
PCT/CN2019/079445 WO2019184840A1 (en) | 2018-03-26 | 2019-03-25 | Method of Delivering Amphiphilic Bioactive Substances Targeting the Respiratory Tract |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202009013QA true SG11202009013QA (en) | 2020-10-29 |
Family
ID=68059444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202009013QA SG11202009013QA (en) | 2018-03-26 | 2019-03-25 | Method of Delivering Amphiphilic Bioactive Substances Targeting the Respiratory Tract |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210128461A1 (en) |
CN (1) | CN111867602A (en) |
AU (1) | AU2019241169A1 (en) |
SG (1) | SG11202009013QA (en) |
TW (1) | TW201946634A (en) |
WO (1) | WO2019184840A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1030599B1 (en) * | 2022-11-23 | 2024-01-09 | Erck Emmanuelle Van | Composition based on essential oils for the treatment and prevention of inflammatory diseases of the airways in animals |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4106026A1 (en) * | 1991-02-26 | 1992-08-27 | Plantamed Arzneimittel Gmbh | PHARMACEUTICAL PREPARATIONS CONTAINING A GALLUS ACID COMPOUND AND / OR QUERCETINE, AND METHOD FOR INSULATING THESE COMPOUNDS |
CN101036771A (en) * | 2006-03-15 | 2007-09-19 | 北京琥珀光华医药科技开发有限公司 | Chinese traditional medicine spray for treating pneumonia and upper respiratory infection |
CN100563670C (en) * | 2007-02-08 | 2009-12-02 | 中国药品生物制品检定所 | A kind of Chinese medicine composition for the treatment of cough, asthma |
CN101234168B (en) * | 2008-03-11 | 2010-09-29 | 浙江大学 | Compound angelica sinensis preparations and preparation and application |
CH703437A2 (en) * | 2010-07-01 | 2012-01-13 | Guenter Holzner | Use of an active mixture of essential oils and volatile synthetic molecules as pulmonary tuberculosis therapy by inhalation of the mixture which is essence of clove, eugenol, thyme, synthetic thymol and methyl jasmonate |
CN204684370U (en) * | 2015-04-21 | 2015-10-07 | 惠州市锦好电子有限公司 | A kind of medicinal atomized inhaler controlled based on module |
CN106729011A (en) * | 2016-11-28 | 2017-05-31 | 医源堂(北京)科技有限公司 | A kind of topical composition |
-
2019
- 2019-03-25 US US15/733,624 patent/US20210128461A1/en active Pending
- 2019-03-25 AU AU2019241169A patent/AU2019241169A1/en active Pending
- 2019-03-25 TW TW108110253A patent/TW201946634A/en unknown
- 2019-03-25 SG SG11202009013QA patent/SG11202009013QA/en unknown
- 2019-03-25 WO PCT/CN2019/079445 patent/WO2019184840A1/en active Application Filing
- 2019-03-25 CN CN201980019869.1A patent/CN111867602A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2019241169A1 (en) | 2020-10-08 |
CN111867602A (en) | 2020-10-30 |
WO2019184840A1 (en) | 2019-10-03 |
TW201946634A (en) | 2019-12-16 |
US20210128461A1 (en) | 2021-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL251462A0 (en) | Pharmaceutical formulations for the oral delivery of peptide or protein drugs | |
IL258464A (en) | Pharmaceutical formulations for the oral delivery of peptide drugs | |
IL258713A (en) | Aerosol delivery system and method of operating the aerosol delivery system | |
HK1246103A1 (en) | Non-combustion type flavor inhaler, flavor inhalation component source unit, and atomizing unit | |
IL283840A (en) | Compositions for the delivery of therapeutic agents and methods of use and making thereof | |
HK1246101A1 (en) | Non-combustion flavor inhaler and aerosol delivery method | |
EP3697481C0 (en) | Nasal drug delivery apparatus and methods of use | |
IL263709A (en) | Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use | |
EP3752231A4 (en) | Method and inhaler for providing two or more substances by inhalation | |
EP3806939A4 (en) | Apparatus for use in delivering respiratory drugs | |
GB201516802D0 (en) | Apparatus and method for determination of the dose of a powder inhalation formulation | |
EP3520633A4 (en) | Flavor inhaler and atomizing unit | |
IL272684A (en) | Exosomes for target specific delivery and methods for preparing and delivering the same | |
HK1247140A1 (en) | Method and system for effective breath-synchronized delivery of medicament to the lungs | |
PT3307293T (en) | Formulations for the treatment of disorders of the mouth, throat and respiratory tract | |
IL282538A (en) | Methods for generating therapeutic delivery platforms | |
HK1257588A1 (en) | Medicine for preventing and treating lung fibrosis and use of the medicine | |
ZA201800470B (en) | An oral pharmaceutical dosage form for the delivery of a peptide and/or protein | |
SG11202009013QA (en) | Method of Delivering Amphiphilic Bioactive Substances Targeting the Respiratory Tract | |
IL275690A (en) | Nanoparticles for the targeted delivery of therapeutic polypeptides | |
RS65157B1 (en) | Respiratory delivery device | |
IL271596A (en) | Compositions for drug delivery and methods of use thereof | |
GB201621559D0 (en) | A method for the preparation of a delivery drug delivery system and a composition therefor | |
ZA201605133B (en) | Pressurised metered dose inhalers and method of manufacture | |
EP3452153A4 (en) | Apparatus for and methods of administering substances into an inhalation flow path |